Pete......i totally agree with yesterday's post. IPIX'S PR was an excellent update and it showed the continuous progression of B AND that it is now being considered for human trials. Despite this splid update on B, the stock went down despite the Dow rising by 1,600 pts. As you pointed out, it just showed us once again, that the short cabal continues to remain in control of the share price until some news is provided that a deal has been signed thst will bring IPIX much needed revenue. The road will be longer than many of us (including myself) thought, but even if it determined that B will not have any part in the treatment of COV-19 ( which I still believe will not be the case), it brought a great amount of exposure to IPIX that should help in our negotiations for OM and IBD, etc. The bottom line, is that you are one of the most positive supportors of IPIX as reflected by your many sound upbeat posts on this board and your significant investment in IPIX.
(3)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links